Blinking stays natural
Because the SmartLids are thin and flexible, patients keep their eyes open and can blink through the whole session.
In-office procedures · Thermal gland expression
The TearCare System warms all four eyelids at once through flexible SmartLids that sense and control temperature, and the clinician then expresses the meibomian glands by hand. It is an in-office treatment for adults with evaporative dry eye disease caused by meibomian gland dysfunction (MGD).
Why practices add it
MGD drives most dry eye disease, and TearCare is built to treat it. SmartLids warm the outside of the eyelids while the patient keeps both eyes open and blinks normally, then the clinician clears the softened glands with manual expression.
Because the SmartLids are thin and flexible, patients keep their eyes open and can blink through the whole session.
Patients can notice a change within a week, and improved gland function may last as long as a year.
In clinical research, TearCare produced significantly better symptom results than the leading prescription dry eye medication, and patients found it more convenient.
Ayres et al. 2023One office treatment can stand in for months of prescription drops, which can ease the burden of daily compliance.
Ten peer-reviewed papers support how well and how safely the TearCare System works.
Gupta et al. 2022; Holland et al. 2022Controlled heat paired with the clinician's hands: single-use SmartLids, a battery-powered SmartHub and manual gland expression.
Flexible single-use pieces with an adhesive back that stick to all four eyelids. Each one carries its own circuits, sensors and microprocessor.
A battery-powered controller with a microprocessor and a rechargeable Li-ion battery good for at least four treatments, plus a countdown display and buttons to adjust temperature.
The lids stay between 41 and 45°C (106 to 113°F) and never above the 47°C (117°F) maximum. Warmth Level 5 is the default and can be turned down if the patient wants.
Within three minutes of taking the SmartLids off, the clinician expresses the meibomian glands with a separate instrument.
In the chair
The lids are cleaned, any contact lenses come out and SmartLids go on all four eyelids before heating starts.
The SmartLids warm the outside of the lids for 15 minutes while the patient's eyes stay open, and the temperature can be turned down mid-session for comfort.
The SmartLids come off and the clinician expresses the meibomian glands within three minutes using a separate instrument.
Contact lenses can go back in 60 minutes after treatment. Patients may see results within a week, lasting as long as a year.
| Treatment time | 15-minute thermal procedure |
|---|---|
| Temperature range | 41–45°C (106–113°F) |
| Maximum allowable temperature | 47°C (117°F) |
| Default setting | Warmth Level 5, adjusted with the +/- buttons |
| SmartLids | Single-use, adhesive, sensor-controlled; four pieces (a left and right pair) covering all four lids |
| Connection | 4-foot cable from the SmartLids to the SmartHub (L and R ports) |
| Power | Rechargeable Li-ion battery, at least 4 treatments per charge |
| Patient age | Adults 22 and older |
The TearCare® System is a thermal-activated gland expression therapy that improves meibomian gland function in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
Heating takes 15 minutes, and the clinician expresses the meibomian glands within three minutes after the SmartLids come off.
No. The flexible SmartLids let patients keep their eyes open and blink normally, and blinking also helps spread the heat during treatment.
Take the lenses out before treatment. They can go back in 60 minutes afterward.
Often within a week, and the benefit may last up to a year.
No. Each set is single-use, because reusing them risks cross-contamination.
Patients under 22, those with a pacemaker or implantable cardiac defibrillator, recent eye or lid surgery or injury, active ocular infection or inflammation, or a known allergy to acrylate, silicone tissue adhesive or copper. The full contraindications list is above.
TearCare is an in-office heat treatment for adults with evaporative dry eye from MGD, finished with gland expression by the clinician.
TearCare System is a trademark of Sight Sciences. Read the complete manufacturer instructions for use, including every warning, precaution and contraindication, before use. Individual results vary.